News Search Results
May 18, 2026, 20:00 ET Accro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases
SUZHOU, China, May 18, 2026 /PRNewswire/ -- Accro Bioscience Inc. ("Accro Bioscience"), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulatory cell death for immune mediated diseases,
More news about: Accro Bioscience Inc.
May 18, 2026, 20:00 ET Full-Life Technologies Announces US$150 Million Financing to Accelerate Multiple Clinical Stage Assets and Manufacturing Capabilities
across 16 USD and RMB funds and has invested in over 460 companies worldwide. Vivo Capital focuses exclusively on the healthcare sector, including biotechnology, pharmaceuticals, medical devices, and pharma services, with an emphasis on the world's largest and fastest-growing markets. The firm is differentiated
More news about: Full-Life Technologies
May 18, 2026, 19:30 ET WesternU College of Osteopathic Medicine of the Pacific-Northwest Commencement: Healers who believe in humanity
Oregon and Pomona, Calif., is an independent nonprofit health professions university, conferring degrees in osteopathic medicine, physical therapy, biotechnology and pharmaceutical sciences, dental medicine, medical sciences, nursing, optometry, pharmacy, physician assistant studies, podiatric medicine, and
More news about: Western University of Health Sciences (WesternU)
May 18, 2026, 19:00 ET WesternU CHS-Northwest Commencement 2026: Find your calling
www.westernu.edu), located in Pomona, Calif. and Lebanon, Ore., is an independent nonprofit health professions university, conferring degrees in biotechnology and pharmaceutical sciences, dental medicine, medical sciences, nursing, optometry, osteopathic medicine, pharmacy, physical therapy, physician
More news about: Western University of Health Sciences (WesternU)
May 18, 2026, 16:05 ET REGENXBIO to Participate in Upcoming Investor Conferences
replays of the webcasts will be available for approximately 30 days following the events.ABOUT REGENXBIO Inc. REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
May 18, 2026, 16:00 ET Palatin to Begin Trading on Nasdaq Stock Exchange
the market close on May 28, 2026."We are pleased to announce our listing on the Nasdaq Capital Market and to join a community of leading biotechnology companies," said Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies. "We believe the move to Nasdaq will improve the
More news about: Palatin Technologies, Inc.
May 18, 2026, 15:45 ET "Lean" Strengthens Saudi Arabia's Presence in Global Digital Health and Precision Medicine Ecosystems
innovation, aligned with the Kingdom's broader ambitions under Saudi Vision 2030 to position itself as a global hub for advanced technologies, research, biotechnology, and innovation.As a key enabler of Saudi Arabia's digital health ecosystem, Lean develops and operates national digital health platforms
More news about: Lean Business Services
May 18, 2026, 15:18 ET UNCG Awarded $2 Million to Grow Bioindustrial Manufacturing Workforce in North Carolina
operators, scientists, and more. While the United States has led the world in biotechnology since the 1970s, in recent years China has surged ahead in key emerging areas, leading to increased federal investment in biotechnology initiatives.The UNCG project will be housed in iCOMMAND, the university's
More news about: University of North Carolina Greensboro
May 18, 2026, 14:05 ET Lupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Pharmaceuticals, Inc.
May 18, 2026, 13:03 ET Lifespan Vision Ventures Leads Violet Therapeutics' $4.75M Seed Extension Financing
Violet Therapeutics is a preclinical-stage biotechnology company developing first-in-class therapies for neurodegenerative disease by mapping disease-relevant cell-to-cell signaling interactions in the
More news about: LifeSpan Vision Ventures
May 18, 2026, 13:03 ET Lifespan Vision Ventures Leads Violet Therapeutics' $4.75M Seed Extension Financing
Violet Therapeutics is a preclinical-stage biotechnology company developing first-in-class therapies for neurodegenerative disease by mapping disease-relevant cell-to-cell signaling interactions in the
More news about: LifeSpan Vision Ventures
May 18, 2026, 12:21 ET IBRX 8-DAY DEADLINE ALERT: ImmunityBio (IBRX) Investors Face Losses Amid FDA Warning Regarding Unsupported Cancer Treatment Claims -- Hagens Berman
844-916-0895ImmunityBio, Inc. (IBRX) Securities Class Action: ImmunityBio is a biotechnology company focused on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system
More news about: Hagens Berman Sobol Shapiro LLP
May 18, 2026, 11:45 ET Luminex Multiplex Assays Market Projected to Reach USD 3.89 Billion by 2033, Driven by Rising Demand for High-Throughput Biomarker Profiling and Standardized Multiplex Testing Workflows: Verified Market Research
transitioning from exploratory tools toward routine workflow infrastructure.Growth of Outsourced Research ModelsPharmaceutical and biotechnology organizations continue increasing reliance on external research partnerships.Expansion of CRO ecosystems is strengthening the installed base
More news about: Verified Market Research
May 18, 2026, 11:29 ET Lydia Field Joins Family Law Group at Rubin Rudman
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; hospitality companies; regulated industries, public entities and municipalities; insurance companies
More news about: Rubin Rudman
May 18, 2026, 10:01 ET Multiplex Assays Market worth $10.65 billion by 2031 | MarketsandMarkets™
market share in the multiplex assay market. This growth can be attributed to a highly advanced healthcare industry, the presence of well-established biotechnology and diagnostics companies, and the use of innovative technologies. Additionally, North America benefits from a significant number of advanced hospitals,
More news about: MarketsandMarkets
May 18, 2026, 10:01 ET Telehealth Market Reach US$ 1,027.3 Bn by 2032 Expands Amid Digital Healthcare Adoption and Virtual Care Innovation | Persistence Market
Material (Glass, Stainless Steel, Aluminum, Others), Door Type (Sliding Doors, Swing Doors, Roll-Up Doors, Others), Application (Pharmaceutical, Biotechnology, Medical Device, Electronics and Semiconductor, Food and Beverage, Others), and Regional Analysis for 2026 - 2033About Persistence Market
More news about: Persistence Market Research Pvt. Ltd.
May 18, 2026, 10:00 ET Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference
pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
May 18, 2026, 10:00 ET Major breakthrough of Sanyou Biopharmaceuticals AI-STAL
road ahead is long, and Sanyou looks forward to walking side by side with every innovator in biopharma — together building a brighter future for biotechnology and a stronger shield for human life and health.About SanyouSanyou Biopharmaceuticals is a high-tech biopharmaceutical company
More news about: Sanyou Bio
May 18, 2026, 09:15 ET Bambusa Therapeutics Presents Positive Preliminary Phase 1 BBT002 Data at American Thoracic Society 2026 (ATS 2026) International Conference and Announces First Patient Dosed in Phase 1b/2a CRSwNP Trial
BOSTON, May 18, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Bambusa Therapeutics), a clinical-stage biotechnology company advancing next-generation, long-acting bispecific antibodies for immunology and inflammation, today announced the presentation of preliminary
More news about: Bambusa Therapeutics, Inc.
May 18, 2026, 09:05 ET BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency
hearing loss, calcification in arteries and joints, and heart problems.About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based
More news about: BioMarin Pharmaceutical Inc.
May 18, 2026, 09:02 ET InterVenn Appoints Industry Leaders Alec Ford and Mitch Levine to Board of Directors
practice and unlock a new frontier in precision medicine."Alec Ford has over 30 years of experience in the genomics, pharmaceutical, and biotechnology industries, and has a proven track record driving commercial growth and performance for businesses in highly competitive and regulated biomedical
More news about: InterVenn Biosciences
May 18, 2026, 09:00 ET PRCCI Marks 10 Years Positioning Puerto Rico on the Global Clinical Research Map
for conducting complex and innovative clinical studies.PRCCI has also built strong relationships with leading global pharmaceutical and biotechnology companies, including Pfizer, Eli Lilly, Merck, Sanofi, Amgen, AbbVie, Bristol Myers Squibb, Novartis, and GSK, as well as top contract research
More news about: Puerto Rico Consortium for Clinical Investigation (PRCCI)
May 18, 2026, 08:31 ET MetaVia to Present Obesity Data at the American Diabetes Association's (ADA) 2026 Scientific Sessions
CAMBRIDGE, Mass., May 18, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that three late-breaking abstracts highlighting its cardiometabolic assets,
More news about: MetaVia Inc.
May 18, 2026, 08:23 ET MS 파마, 올라얀 파이낸싱 컴퍼니로부터 전략적 성장 투자 유치 발표
승인을 받은 사우디아라비아에서 바이오시밀러 분야 내 MS 파마의 리더십을 기반으로 한다. 올해 회사는 또한 사우디 시장에 현지 제조 바이오의약품을 공급하는 첫 번째 공급업체가 될 계획이다. 이러한 이정표들은 사우디 국가 생명공학 전략(Saudi National Biotechnology Strategy)과 비전 2030(Vision 2030)에 따른 현지화에 대한 회사의 약속을 강화한다. 역내 전반에 걸친 고품질 바이오로직 치료제의 확장과 지역 및 국제 보건 당국과의 긴밀한 협력을 통해 MS 파마는 최고 수준의 규제 우수성과 품질에 전념하고
More news about: MS Pharma
May 18, 2026, 08:12 ET MS Pharma、Olayan Financing Companyによる戦略的成長投資を発表
Pharmaのバイオシミラー分野でのリーダーシップ、特にサウジアラビアでの実績を基盤としており、同国では、同社の生物製剤製造拠点が生物製剤製造に関するSFDAのGMP承認をサウジアラビア王国で初めて取得しました。また同社は今年、サウジアラビア市場に現地製造の生物製剤を供給する初のサプライヤーとなることも計画しています。これらのマイルストーンは、サウジアラビア国家バイオテクノロジー戦略（Saudi National Biotechnology Strategy）およびVision 2030の下での現地化に対する同社の取り組みを一段と強化するものです。MS Pharmaは、高品質な生物製剤による治療を地域全体に広げ、地域および国際的な保健当局と緊密に連携することで、薬事規制面の卓越性と品質における最高水準の維持に引き続き注力しています。MS
More news about: MS Pharma